Disclaimer: This comprehensive clinical reference is intended for educational purposes and to provide authoritative, evidence-based medical information for healthcare professionals. It is modeled after clinical reference systems like UpToDate. The information provided herein is not a substitute for professional medical advice, diagnosis, or treatment. Clinical decisions must always be made by a qualified healthcare professional based on the specific circumstances of each patient, considering their individual medical history, current clinical presentation, and local guidelines. Dosages and treatment regimens should be verified against current prescribing information and local formularies. Always exercise independent clinical judgment.

---

Oropharyngitis In Children

Overview

• Definition: Oropharyngitis, commonly known as "sore throat," is an acute inflammation of the pharynx and tonsils, often accompanied by pain, dysphagia, and fever. It is a highly prevalent condition in children.
• Epidemiology:
  • One of the most common reasons for primary care visits in children.
  • Peak incidence occurs in school-aged children (5-15 years).
  • Viral etiologies account for 70-85% of cases, while Group A Streptococcus (GAS), or Streptococcus pyogenes, is responsible for 15-30% of cases in children and adolescents, and less than 5% in children under 3 years of age.
  • Seasonal peaks typically occur in late fall, winter, and early spring.
• Classification:
  • Viral Oropharyngitis: Caused by a wide range of viruses (e.g., rhinovirus, adenovirus, influenza virus, parainfluenza virus, enterovirus, Epstein-Barr virus [EBV], herpes simplex virus [HSV]).
  • Bacterial Oropharyngitis: Predominantly caused by Group A Streptococcus (GAS). Less common bacterial causes include Arcanobacterium haemolyticum, Mycoplasma pneumoniae, Chlamydophila pneumoniae, and Group C/G Streptococcus.
  • Non-infectious Oropharyngitis: Less common, can be due to allergies, irritants (e.g., smoke), or acid reflux.

Pathophysiology

• Mechanism:
  • Viral: Viruses infect and replicate in the epithelial cells of the pharynx, leading to local inflammation, edema, and cellular damage. The immune response to viral antigens contributes to symptoms.
  • Bacterial (GAS): S. pyogenes adheres to pharyngeal epithelial cells via surface proteins (e.g., M protein, lipoteichoic acid). It produces various virulence factors including pyrogenic exotoxins (superantigens responsible for scarlet fever rash), streptolysins (hemolysis), and streptokinase, leading to direct tissue damage and a robust inflammatory response. The M protein's structural similarity to human tissue antigens can trigger autoimmune reactions in susceptible individuals, leading to complications like acute rheumatic fever (ARF).
• Risk Factors:
  • Age: School-aged children (5-15 years) are at highest risk for GAS pharyngitis. Infants and toddlers are more susceptible to viral causes.
  • Close Contact: Living in crowded conditions (e.g., dormitories, military barracks, daycare centers, schools) facilitates transmission.
  • Seasonality: Increased incidence of both viral and bacterial infections during colder months.
  • Lack of Prior Immunity: Naive immune system in young children makes them more susceptible.
  • Immunocompromised State: Increases susceptibility to more severe or unusual pathogens.
• Protective Factors:
  • Good Hand Hygiene: Frequent handwashing, especially after coughing, sneezing, or contact with sick individuals.
  • Avoidance of Close Contact: Limiting exposure to individuals with respiratory symptoms.
  • Vaccination: Immunization against influenza and other vaccine-preventable respiratory viruses can reduce overall viral burden.
  • Nutritional Status: General good health and nutrition support a robust immune system.

Clinical Presentation

Signs and Symptoms

Clinical differentiation between viral and bacterial (GAS) pharyngitis can be challenging as symptoms overlap significantly. - Cardinal Features: * Sore throat (pharyngalgia): Often sudden onset in GAS, more gradual in viral. * Dysphagia/Odynophagia: Painful swallowing, leading to reduced oral intake. * Fever: Common in both, often higher (≥38.5°C or 101.3°F) and sudden in onset with GAS. - Early Signs (GAS vs. Viral): * More suggestive of GAS: Abrupt onset of sore throat, fever, headache, abdominal pain, nausea, vomiting. Absence of cough, coryza, and conjunctivitis. * More suggestive of Viral: Gradual onset, rhinorrhea (runny nose), cough, hoarseness, conjunctivitis, oral ulcers (herpangina), diarrhea. - Advanced Signs: * GAS: Scarlatiniform rash (sandpaper texture, particularly prominent in skinfolds - Pastia's lines), palatal petechiae, strawberry tongue (red, prominent papillae). * Severe Viral (e.g., infectious mononucleosis): Marked cervical lymphadenopathy (posterior), hepatosplenomegaly, prolonged fatigue. - Atypical Presentations: * Infants and Young Children (<3 years): May present with non-specific symptoms such as fussiness, poor feeding, low-grade fever, anorexia, or vomiting/diarrhea, without significant complaints of sore throat. GAS can present as impetigo (pyoderma). * Adults (though topic is children): Less likely to develop ARF. * Chronic carriers of GAS: May be asymptomatic but test positive for GAS.

Physical Examination

• Inspection:
  • Oropharynx: Erythema of tonsils and pharyngeal wall. May see white or yellow tonsillar exudates (pus), which can be present in both viral (e.g., adenovirus, EBV) and bacterial (GAS) infections.
  • Palate: Petechiae (small red spots) on the soft palate are highly suggestive of GAS.
  • Tonsils: May appear swollen and hyperemic. Unilateral tonsillar enlargement or uvular deviation can suggest peritonsillar abscess.
  • Skin: Scarlatiniform rash on trunk and extremities (suggests scarlet fever due to GAS).
  • Conjunctiva: Conjunctivitis is common in viral pharyngitis (e.g., adenovirus).
• Palpation:
  • Lymph Nodes: Tender, enlarged anterior cervical lymph nodes are common in GAS pharyngitis. Generalized lymphadenopathy (including posterior cervical and axillary) may suggest infectious mononucleosis.
• Special Tests:
  • No specific bedside "special tests" for pharyngitis itself beyond a thorough visual and tactile examination. Airway assessment is paramount if stridor or respiratory distress is present.

Diagnostic Approach

History Taking

• Key Questions:
  • Onset and Duration: Acute (GAS) vs. gradual (viral)? How long has the sore throat been present?
  • Associated Symptoms: Presence or absence of cough, coryza, conjunctivitis, hoarseness, oral ulcers (suggests viral). Presence of headache, abdominal pain, vomiting, rash (suggests GAS).
  • Fever Pattern: Onset, highest temperature, associated chills.
  • Exposure: Contact with sick individuals (especially those with strep throat), recent travel, daycare/school attendance.
  • Past Medical History: History of rheumatic fever, recurrent strep throat, recent antibiotic use, allergies.
  • Immunization Status: Up-to-date on routine childhood vaccinations.
• Red Flags: Warning signs that necessitate urgent evaluation for more serious conditions (e.g., epiglottitis, retropharyngeal abscess, peritonsillar abscess):
  • Drooling: Inability to swallow saliva.
  • Stridor: High-pitched inspiratory sound, indicating upper airway obstruction.
  • Muffled or "Hot Potato" Voice: Characteristic of peritonsillar or retropharyngeal abscess.
  • Severe Dysphagia/Odynophagia: Refusal to swallow or severe pain.
  • Respiratory Distress: Tachypnea, retractions, nasal flaring, cyanosis.
  • Trismus: Difficulty opening the mouth.
  • Neck Stiffness or Torticollis: Suggests deep neck space infection.

Laboratory Tests

The primary goal of testing is to identify and treat GAS pharyngitis to prevent acute rheumatic fever. - First-Line: * Rapid Antigen Detection Test (RADT): Performed on a throat swab. Detects GAS carbohydrate antigen. * Sensitivity: 70-90% (lower than culture). * Specificity: 95-99% (high, meaning few false positives). * Clinical Use: If positive, confirms GAS and allows for prompt antibiotic initiation. If negative, must be followed by a throat culture in children and adolescents due to lower sensitivity, as missing GAS could lead to ARF. In adults, a negative RADT does not typically require confirmatory culture, as the risk of ARF is very low. * Nucleic Acid Amplification Test (NAAT): Performed on a throat swab. More sensitive than RADT and comparable to culture. * Sensitivity: 92-99%. * Specificity: 95-99%. * Clinical Use: Can be used as a standalone test. A negative NAAT in children generally does not require a confirmatory culture. Results available within minutes to hours. - Confirmatory: * Throat Culture: Gold standard for diagnosing GAS pharyngitis. * Sensitivity: 90-95%. * Specificity: >99%. * Clinical Use: Routinely recommended to confirm negative RADT results in children and adolescents to prevent missed GAS infections. Results typically take 24-48 hours. - Monitoring: * Generally not needed for uncomplicated pharyngitis after diagnosis and initiation of treatment. * ASO/Anti-DNase B titers: Not used for diagnosing acute pharyngitis. Used to confirm a recent GAS infection in suspected post-streptococcal complications like ARF or PSGN, typically drawn 2-3 weeks after infection.

Imaging

• Recommended: Not routinely recommended for the diagnosis of uncomplicated oropharyngitis.
• Advanced: Imaging is indicated only when there are concerns for complications, particularly deep neck space infections or epiglottitis.
  • Lateral Neck X-ray (Soft Tissue): Can show enlarged epiglottis ("thumb sign" for epiglottitis) or retropharyngeal swelling/air.
  • Computed Tomography (CT) Scan of the Neck with Contrast: Preferred imaging modality for suspected peritonsillar abscess, retropharyngeal abscess, or parapharyngeal abscess to delineate the extent of infection and guide drainage. Should be performed in a stable patient.
  • Ultrasound: Can be used to differentiate cellulitis from abscess in peritonsillar region, but limited by operator experience and patient cooperation.

Management

Acute Management

• Immediate:
  • Symptomatic Relief: Focus on pain and fever control regardless of etiology.
    • Acetaminophen (Paracetamol): 10-15 mg/kg orally every 4-6 hours, not to exceed 75 mg/kg/day or 4000 mg/day (whichever is less).
    • Ibuprofen: 5-10 mg/kg orally every 6-8 hours, not to exceed 40 mg/kg/day.
    • Warm saline gargles (for older children), throat lozenges (for children >4 years to prevent choking), cool liquids, soft foods.
• Stabilization:
  • Airway Management: If red flag signs (stridor, drooling, respiratory distress) are present, immediate airway assessment and stabilization are paramount. This may involve positioning, supplemental oxygen, or intubation in severe cases, ideally in a controlled environment like an operating room.
  • Fluid Management: Ensure adequate hydration, especially if dysphagia is severe. Intravenous fluids may be necessary.
• Emergency:
  • Deep Neck Space Infections (e.g., Peritonsillar Abscess, Retropharyngeal Abscess, Epiglottitis): Requires urgent consultation with ENT or critical care. Management often includes:
    • Airway protection.
    • Intravenous broad-spectrum antibiotics: Often empiric until cultures return (e.g., Clindamycin, Ampicillin-Sulbactam).
    • Surgical drainage: For abscesses, once stable. Epiglottitis typically requires intubation.

Chronic Management

Oropharyngitis is an acute condition; "chronic management" typically refers to long-term follow-up for recurrent infections or complications. - Pharmacological: * Antibiotics for GAS Pharyngitis: To eradicate the organism, prevent ARF, reduce local suppurative complications, and limit transmission. Treatment should be initiated within 9 days of symptom onset to prevent ARF. * First-Line: * Penicillin V: 250 mg orally 2-3 times a day for 10 days (children <27 kg) or 500 mg orally 2 times a day for 10 days (children ≥27 kg and adolescents/adults). Penicillin V is preferred due to narrow spectrum, efficacy, and low cost. * Amoxicillin: 50 mg/kg orally once daily (max 1000 mg/day) or 25 mg/kg orally twice daily (max 500 mg/dose) for 10 days. Often preferred in children due to better palatability and once-daily dosing option. * Benzathine Penicillin G (IM): Single intramuscular injection of 600,000 units (children <27 kg) or 1,200,000 units (children ≥27 kg and adolescents/adults). Used for compliance concerns, but painful. * For Penicillin Allergy (non-anaphylactic): * Cephalexin: 25-50 mg/kg/day orally in 2 divided doses for 10 days (max 1000 mg/day). * Cefadroxil: 30 mg/kg/day orally once daily (max 1000 mg/day) for 10 days. * For Penicillin Allergy (Type I hypersensitivity/anaphylaxis): * Azithromycin: 12 mg/kg orally once daily (max 500 mg/day) for 5 days. (Note: Macrolide resistance in GAS can be an issue in some areas). * Clindamycin: 7 mg/kg orally 3 times a day (max 300 mg/dose) for 10 days. * Antivirals: Not typically used for common viral pharyngitis. May be considered for severe cases of influenza (oseltamivir) or HSV (acyclovir) pharyngitis. - Non-pharmacological: * Rest: Adequate sleep supports immune function. * Hydration: Encourage fluid intake to prevent dehydration, especially with fever and dysphagia. * Diet: Soft, easy-to-swallow foods. Avoid irritating foods (acidic, spicy). * Humidifier: Cool mist humidifier may soothe irritated mucous membranes. * School/Daycare Exclusion: Children should remain home until afebrile for 24 hours AND, if diagnosed with GAS, have been on antibiotics for at least 24 hours. - Monitoring: * Clinical Improvement: Symptoms should improve within 24-48 hours of starting appropriate antibiotics for GAS. * Compliance: Emphasize completion of the full 10-day antibiotic course for GAS, even if symptoms improve earlier, to ensure eradication and prevent ARF. * Recurrent Symptoms: Re-evaluate if symptoms persist or worsen after 48-72 hours of treatment (consider non-compliance, alternative diagnosis, antibiotic resistance, or complications).

Treatment Algorithms

• First-Line (General Approach):
  1. Assess clinical likelihood of GAS: Use clinical prediction rules like the Modified Centor Score (see Clinical Pearls).
  2. Test for GAS: For children and adolescents, perform RADT or NAAT.
  3. Symptomatic Management: Provide analgesics/antipyretics.
  4. If GAS positive: Initiate first-line antibiotics (Penicillin V, Amoxicillin).
  5. If RADT negative in children/adolescents: Confirm with throat culture. If culture positive, initiate antibiotics. If culture negative, no antibiotics needed.
  6. If Viral (no GAS detected): Continue symptomatic management. No antibiotics.
• Second-Line (Antibiotic Treatment for GAS, specific cases):
  • Non-anaphylactic Penicillin Allergy: Cephalexin or Cefadroxil for 10 days.
  • Anaphylactic Penicillin Allergy: Azithromycin for 5 days or Clindamycin for 10 days.
  • Treatment Failure/Recurrence (documented GAS): Consider non-compliance, re-infection, or penicillin tolerance (rare). May use amoxicillin-clavulanate or clindamycin, or intramuscular penicillin G.
• Refractory Cases (Failure to Respond):
  • Re-evaluate Diagnosis: Is it truly GAS? Could it be a viral infection masquerading as bacterial, or another bacterial pathogen (e.g., Arcanobacterium haemolyticum)?
  • Check Compliance: Ensure full antibiotic course was taken.
  • Consider Complications: Look for signs of abscess (peritonsillar, retropharyngeal).
  • Consider Viral Superinfection: Viral illness occurring concurrently or after GAS.
  • Consider Carrier State: Asymptomatic GAS carriage being treated unnecessarily for viral symptoms.
  • Consider PANDAS/PANS: For recurrent strep infections associated with neuropsychiatric symptoms, though this is a complex and controversial area.

Complications

• Common (Suppurative):
  • Peritonsillar Abscess (Quinsy): Collection of pus behind the tonsil. Presents with severe unilateral sore throat, fever, muffled voice, trismus, and uvular deviation. Requires drainage and antibiotics.
  • Retropharyngeal Abscess: Abscess in the space behind the pharynx. Presents with severe sore throat, fever, dysphagia, neck stiffness, drooling, and potentially airway obstruction. Life-threatening. Requires surgical drainage and IV antibiotics.
  • Otitis Media: Middle ear infection.
  • Sinusitis: Inflammation of the paranasal sinuses.
• Serious (Non-suppurative, immune-mediated): These are largely prevented by timely and appropriate antibiotic treatment of GAS.
  • Acute Rheumatic Fever (ARF): A systemic inflammatory disease affecting the heart, joints, brain, and skin. Can lead to permanent rheumatic heart disease. Occurs 2-4 weeks after untreated or inadequately treated GAS pharyngitis.
  • Post-Streptococcal Glomerulonephritis (PSGN): Kidney inflammation that can cause hematuria, edema, and hypertension. Can occur after GAS pharyngitis or skin infection. Antibiotic treatment of pharyngitis does NOT prevent PSGN.
  • Pediatric Autoimmune Neuropsychiatric Disorders Associated with Streptococcal Infections (PANDAS): A controversial diagnosis linking rapid onset of obsessive-compulsive disorder or tic disorders to GAS infection.
• Long-term:
  • Chronic Tonsillitis/Recurrent Pharyngitis: Frequent episodes of pharyngitis (may or may not be GAS). Can lead to consideration for tonsillectomy (criteria vary, e.g., >7 episodes in 1 year, >5/year for 2 years, >3/year for 3 years).

Prognosis

• Factors:
  • Etiology: Viral pharyngitis is self-limiting with an excellent prognosis, resolving within 7-10 days. GAS pharyngitis also has an excellent prognosis with appropriate antibiotic treatment.
  • Timeliness of Treatment: Prompt antibiotic treatment of GAS significantly reduces the risk of ARF.
  • Development of Complications: Prognosis worsens significantly if complications like ARF (especially cardiac involvement) or deep neck space infections occur.
• Survival: Excellent for uncomplicated cases. Mortality is extremely rare and usually associated with severe, untreated complications (e.g., airway obstruction from abscess, fulminant rheumatic carditis).
• Quality of Life: For uncomplicated cases, quality of life quickly returns to baseline after recovery. Rheumatic heart disease can significantly impair long-term quality of life and may require lifelong medical management or surgical intervention.

Prevention

• Primary (Preventing initial occurrence):
  • Hand Hygiene: Frequent and thorough handwashing with soap and water, especially after coughing or sneezing and before eating. Alcohol-based hand sanitizers are also effective.
  • Respiratory Etiquette: Covering coughs and sneezes.
  • Avoidance of Sick Contacts: Limiting close contact with individuals exhibiting symptoms of respiratory infection.
  • Environmental Cleaning: Regular cleaning of frequently touched surfaces.
  • Vaccination: Routine childhood vaccinations (e.g., influenza) to reduce the burden of viral respiratory illnesses.
• Secondary (Early detection and intervention):
  • Prompt Diagnosis and Treatment of GAS: The most crucial secondary prevention strategy is to identify and treat GAS pharyngitis with appropriate antibiotics to prevent ARF. This emphasizes the importance of testing for GAS in children with sore throats.
• Tertiary (Preventing complications/recurrences):
  • Complete Antibiotic Course: Ensuring children complete the full 10-day antibiotic course for GAS, even if symptoms improve, to ensure bacterial eradication.
  • Secondary Prophylaxis for ARF: For individuals who have had a documented episode of ARF, continuous antibiotic prophylaxis (e.g., penicillin V or monthly intramuscular benzathine penicillin G) is recommended to prevent recurrent GAS infections and subsequent recurrences of ARF, which can worsen cardiac damage.
  • Tonsillectomy: May be considered for children with recurrent documented episodes of pharyngitis (with or without positive strep tests) that significantly impact quality of life, using established criteria.

Special Populations

• Pediatric:
  • Infants and Toddlers (<3 years): Less likely to develop GAS pharyngitis, and the risk of ARF is very low. However, GAS can present as non-specific symptoms (fussiness, nasal discharge, low-grade fever) or impetigo. Testing for GAS in this age group is typically reserved for those with scarlet fever or a strong epidemiologic link to a GAS outbreak.
  • Children 3-15 years: Highest risk for GAS and ARF. Testing for GAS is highly recommended in this age group when clinical suspicion exists.
  • Adolescents: Risk of ARF declines with age but remains significant. Also consider other causes like Arcanobacterium haemolyticum and infectious mononucleosis.
• Geriatric: While the topic is children, it's worth noting that GAS pharyngitis is rare in the elderly, and the risk of ARF is exceedingly low. Symptomatic management is often sufficient, and testing is less commonly indicated unless complications or atypical presentations warrant it.
• Pregnancy: Not applicable for children.
• Comorbidities:
  • Immunocompromised Children: More susceptible to severe infections and unusual pathogens. Diagnosis and management may be more complex, often requiring broader empiric antibiotic coverage and close monitoring.
  • Children with History of Rheumatic Fever/Rheumatic Heart Disease: Timely and effective treatment of GAS is critical. These children should also be considered for lifelong secondary prophylaxis.
  • Children with Recurrent Pharyngitis: Evaluate for underlying causes such as immune deficiencies, allergies, or chronic adenotonsillar hypertrophy.

Clinical Pearls

• Diagnostic:
  • Appearance is Deceiving: Do not rely solely on the appearance of the throat (e.g., presence or absence of exudates) to differentiate between viral and GAS pharyngitis. Exudates can be present in both, and their absence does not rule out GAS.
  • Centor Score (Modified Centor Score): A clinical prediction rule to estimate the probability of GAS pharyngitis and guide testing. Each of the following is worth 1 point:
    1. Tonsillar exudates
    2. Swollen, tender anterior cervical lymph nodes
    3. Absence of cough
    4. History of fever (reported or temp ≥38°C)
    5. Age 3-14 years (+1 point)
    6. Age 15-44 years (0 points)
    7. Age ≥45 years (-1 point) * Interpretation:
       • Score ≤1: Low probability of GAS, typically no testing or antibiotics needed.
       • Score 2-3: Intermediate probability, consider RADT/NAAT.
       • Score ≥4: High probability, consider empiric treatment or prompt testing and treat if positive.
       • Caveat: Centor score is a guide; definitive diagnosis requires testing in children due to ARF risk.
  • "Strep Throat" Testing Strategy: For children and adolescents with pharyngitis symptoms, always test for GAS. A negative RADT/NAAT in children must be followed by a confirmatory throat culture (unless a highly sensitive NAAT is used as the primary test).
• Treatment:
  • Completing the Course: Emphasize to parents the critical importance of completing the entire 10-day antibiotic course for GAS, even if the child feels better after a few days, to prevent rheumatic fever.
  • Symptomatic Care for Viral Pharyngitis: Do not prescribe antibiotics for viral pharyngitis. Focus on symptomatic relief, patient education, and reassurance.
  • Analgesia is Key: Adequate pain control (with acetaminophen or ibuprofen) is crucial to ensure comfort and adequate fluid intake.
• Pitfalls:
  • Over-prescription of Antibiotics: Leading to antibiotic resistance and unnecessary side effects when viral etiology is likely.
  • Missing GAS Infection: Failure to test or adequately follow up negative rapid tests in children, leading to risk of ARF.
  • Misdiagnosing Deep Neck Space Infections: Attributing severe symptoms like stridor or drooling solely to simple pharyngitis, delaying critical interventions for life-threatening conditions.
  • Treating Asymptomatic Carriers: Identifying and treating a child who is an asymptomatic GAS carrier (positive test but no symptoms), which doesn't prevent ARF and contributes to antibiotic overuse. Only treat symptomatic cases.

Recent Updates

• Guidelines:
  • Infectious Diseases Society of America (IDSA) Guidelines for the Diagnosis and Management of Group A Streptococcal Pharyngitis (2012): Remain the most comprehensive and widely accepted guidelines. They emphasize the importance of rapid testing and culture confirmation in children.
  • American Academy of Pediatrics (AAP) Clinical Practice Guideline for the Diagnosis and Management of Group A Streptococcal Pharyngitis (2012): Consistent with IDSA guidelines.
• Evidence:
  • Point-of-Care Nucleic Acid Amplification Tests (NAATs): Increasing adoption of NAATs in clinical practice due to their high sensitivity (comparable to culture) and rapid turnaround time (often <1 hour), potentially obviating the need for confirmatory cultures for negative results in children.
  • Antibiotic Resistance: Macrolide resistance in GAS varies geographically and is a concern, impacting the choice of antibiotics for penicillin-allergic patients. Penicillin remains universally effective against GAS.
• Controversies:
  • Optimal Testing Strategy: While NAATs are promising, cost-effectiveness and widespread availability still vary. The optimal balance between rapid testing, confirmatory culture, and empiric treatment continues to be debated in different clinical settings.
  • Management of Recurrent Pharyngitis: Defining true recurrent GAS infections versus carrier state, and indications for tonsillectomy for recurrent infections remain areas of clinical judgment and ongoing discussion.
  • PANDAS/PANS: Continued debate regarding the specific diagnostic criteria, prevalence, and management of these proposed conditions.

Key References

• Guidelines:
  • Shulman ST, et al. Clinical Practice Guideline for the Diagnosis and Management of Group A Streptococcal Pharyngitis: 2012 Update by the Infectious Diseases Society of America. Clin Infect Dis. 2012 Nov 15;55(10):e86-102.
  • American Academy of Pediatrics. Group A Streptococcal Infections. In: Kimberlin DW, et al., eds. Red Book: 2021-2024 Report of the Committee on Infectious Diseases. 32nd ed. Itasca, IL: American Academy of Pediatrics; 2021.
• Studies:
  • Bisno AL, et al. A clinical rule for the diagnosis of streptococcal pharyngitis. Ann Intern Med. 1997 Jun 1;126(11):901-2. (Original Centor score validation)
  • Gerber MA, et al. Rapid detection of Group A streptococcal pharyngitis. Ann Emerg Med. 1999 Sep;34(3):369-71. (Review of RADT performance)
• Reviews:
  • Wessels MR. Streptococcal Pharyngitis. N Engl J Med. 2022 Feb 17;386(7):645-655.

---

Disclaimer: This information is for the use of healthcare professionals and is not intended to provide medical advice or diagnosis. Always consult with a qualified healthcare professional for any health concerns or before making any decisions related to patient care. While efforts have been made to ensure the accuracy and completeness of the information, medical knowledge is constantly evolving, and errors may occur. The authors and publishers are not liable for any consequences arising from the use of this information.